Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 13;15(11):e0272124.
doi: 10.1128/mbio.02721-24. Epub 2024 Oct 23.

Minor prion substrains overcome transmission barriers

Affiliations

Minor prion substrains overcome transmission barriers

Benjamin S Steadman et al. mBio. .

Abstract

Mammalian prion diseases are infectious neurodegenerative diseases caused by the self-templating form of the prion protein PrPSc. Much evidence supports the hypothesis that prions exist as a mixture of a dominant strain and minor prion strains. While it is known that prions can infect new species, the relative contribution of the dominant prion strain and minor strains in crossing the species barrier is unknown. We previously identified minor prion strains from a biologically cloned drowsy (DY) strain of hamster-adapted transmissible mink encephalopathy (TME). Here we show that these minor prion strains have increased infection efficiency to rabbit kidney epithelial cells that express hamster PrPC compared to the dominant strain DY TME. Using protein misfolding cyclic amplification (PMCA), we found that the dominant strain DY TME failed to convert mouse PrPC to PrPSc, even after several serial passages. In contrast, the minor prion strains isolated from biologically cloned DY TME robustly converted mouse PrPC to PrPSc in the first round of PMCA. This observation indicates that minor prion strains from the mutant spectra contribute to crossing the species barrier. Additionally, we found that the PMCA conversion efficiency for the minor prion strains tested was significantly different from each other and from the short-incubation period prion strain HY TME. This suggests that minor strain diversity may be greater than previously anticipated. These observations further expand our understanding of the mechanisms underlying the species barrier effect and has implications for assessing the zoonotic potential of prions.

Importance: Prions from cattle with bovine spongiform encephalopathy have transmitted to humans, whereas scrapie from sheep and goats likely has not, suggesting that some prions can cross species barriers more easily than others. Prions are composed of a dominant strain and minor strains, and the contribution of each population to adapt to new replicative environments is unknown. Recently, minor prion strains were isolated from the biologically cloned prion strain DY TME, and these minor prion strains differed in properties from the dominant prion strain, DY TME. Here we found that these minor prion strains also differed in conversion efficiency and host range compared to the dominant strain DY TME. These novel findings provide evidence that minor prion strains contribute to interspecies transmission, underscoring the significance of minor strain components in important biological processes.

Keywords: interspecies transmission; prion disease; prion strain.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
High PMCA conversion efficiency minor prion strains emerge from DY TME. Western blot analysis of intraspecies PMCA reactions seeded with 10-fold serial dilutions of (A) biologically cloned DY TME brain or minor prion strains isolated from DY by either the (B) CSSA or the (C) PSSA. Each prion sample was examined with a minimum of three biological replicates consisting of four technical replicates each. Uninfected (UN) brain homogenate or HY TME-infected brain homogenate seeded PMCA reactions were included in each experiment as negative and positive controls, respectively. CSSA, conformational stability selection assay; PSSA, proteinase strain selection assay.
Fig 2
Fig 2
Hamster prion strains differ in PMCA conversion efficiency. Quantification of PMCA conversion efficiency of 10-fold serial dilutions of brain homogenate seeded into intraspecies PMCA reactions. Bar graphs represent all technical replicates for each prion strain, with means and standard deviations. Individual animals for each strain are represented by different colored triangles. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. CSSA1, DY 4M CSSA hamster passage 1; CSSA2, DY 4M CSSA hamster passage 2; CSSA3, DY 4M CSSA hamster passage 3; DY, drowsy hamster-adapted TME; HY, hyper-hamster-adapted TME; PSSA1, DY PSSA hamster passage 1; PSSA-PMCA, DY PSSA hamster PMCA round 4; UN, uninfected hamster.
Fig 3
Fig 3
Interspecies prion conversion by minor prion strains. (A) Western blot analysis of PMCA reactions using either hamster or mouse as the template for conversion seeded with either UNHa brain, UNMo brain, DY TME-infected hamster brain homogenate, the minor prion strain from DY 4M CSSA3, or RML mouse-adapted scrapie. (B) Western blot analysis of PMCA reactions seeded with 10-fold serial dilutions (50–0.05 μg eq.) of brain homogenate from uninfected and prion-infected brain homogenates. Each sample was tested by PMCA between three to eight biological replicates consisting of four technical replicates each. CSSA1, DY 4M CSSA hamster passage 1; CSSA2, DY 4M CSSA hamster passage 2; CSSA3, DY 4M CSSA hamster passage 3; PSSA, DY PSSA hamster PMCA round 4; PSSA1, DY PSSA hamster passage 1; RML, Rocky Mountain Laboratory mouse-adapted scrapie; UNHa, uninfected hamster; UNMo, uninfected mouse.
Fig 4
Fig 4
Hamster prion strains differ in interspecies PMCA conversion efficiency for mice. Quantification of PMCA conversion efficiency of 10-fold serial dilutions of hamster brain homogenate seeded into PMCA reactions using mouse brain homogenate as a template for conversion. Presented are all technical replicates for each prion sample, with means and standard deviations. Individual animals for each strain are represented by different colored triangles. ns, not significant (P > 0.05); **P < 0.01; ***P < 0.001, ****P < 0.0001. CSSA1, DY 4M CSSA hamster passage 1; CSSA2, DY 4M CSSA hamster passage 2; CSSA3, DY 4M CSSA hamster passage 3; DY, drowsy hamster-adapted TME; HY, hyper hamster-adapted TME; PSSA1, DY PSSA hamster passage 1; PSSA-PMCA, DY PSSA hamster PMCA round 4; RML, Rocky Mountain laboratory mouse-adapted scrapie; UNHa, uninfected hamster; UNMo, uninfected mouse.
Fig 5
Fig 5
RK13-HamPrP cells are resistant to infection with DY TME but susceptible to minor DY strains. (A) RK13-HamPrP cells were incubated for 4 weeks in 96-well plates pre-coated with 1% brain homogenates from diseased hamsters inoculated with HY TME, DY TME, and minor strains derived from CSSA and PSSA treatments. A total of 20,000 cells were filtered onto ELISpot plates, digested with PK, denatured with guanidine thiocyanate, and probed with SHA31 PrP antibody. Mean ± standard deviation, counts of prion infected cells from three infected animals, where each of the animals were assayed in triplicate (CSSA and PSSA), or a single animal was assayed in triplicate (HY and DY). Statistical comparison was analyzed by one-way ANOVA with Tukey’s multiple comparison test. **P < 0.01; ***P < 0.001; ****P < 0.0001. (B) Parallel infections with RKV cells serve as negative controls. RKV: RK13 cells transfected with pIRESpuro3 vector do not express hamster PrP. Statistical comparison was analyzed by one-way ANOVA with Tukey’s multiple comparison test; ns, not significant (P > 0.05). (C) Representative wells of infections of RK13-HamPrP-wt cells with DY TME, PSSA1, CSSA1, CSSA2, CSSA3, and HY TME or RKV negative control cells with HY TME prions. Spots: PrPSc of prion infected cells were probed with SHA31 PrP antibody, followed by alkaline phosphatase-conjugated secondary antibody and visualized with NBT/BCIP substrate. ANOVA, analysis of variance; CSSA1, DY 4M CSSA hamster passage 1; CSSA2, DY 4M CSSA hamster passage 2; CSSA3, DY 4M CSSA hamster passage 3; PSSA1, DY PSSA hamster passage 1; RKV, RK-vector.
Fig 6
Fig 6
Theoretical model of prion transmission. (A) Serial intraspecies transmission of a prion strain most often results in the maintenance of the dominant prion strain. (B) Intraspecies transmission in the presence of a selective pressure (e.g., anti-prion drug) can result in the emergence of a pre-existing minor prion strain that has a replicative advantage compared to the parental dominant prion strain. Interspecies transmission can result in a (C) failure to establish infection, (D) the dominant prion strain resulting in the conversion of the new host PrPC to PrPSc, or (E) a minor strain component of the parental prion strain causing the conversion of PrPC to PrPSc in the new host species. Created with BioRender.com.

Similar articles

References

    1. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136–144. doi:10.1126/science.6801762 - DOI - PubMed
    1. Kong Q, Bessen RA. 2017. Prion diseases, p 517–531. In Ikezu T, Gendelman HE (ed), Neuroimmune pharmacology. Springer international publishing, Switzerland.
    1. Ironside JW, Ritchie DL, Head MW. 2018. Prion diseases, p 393–403. In Kovacs GG, Alafuzoff I (ed), Neuropathology. Elsevier B.V.
    1. Orge L, Lima C, Machado C, Tavares P, Mendonça P, Carvalho P, Silva J, Pinto M de L, Bastos E, Pereira JC, Gonçalves-Anjo N, Gama A, Esteves A, Alves A, Matos AC, Seixas F, Silva F, Pires I, Figueira L, Vieira-Pinto M, Sargo R, Pires MDA. 2021. Neuropathology of animal prion diseases. Biomolecules 11:466. doi:10.3390/biom11030466 - DOI - PMC - PubMed
    1. Marsh RF, Bessen RA, Lehmann S, Hartsough GR. 1991. Epidemiological and experimental studies on a new incident of transmissible mink encephalopathy. J Gen Virol 72 (Pt 3):589–594. doi:10.1099/0022-1317-72-3-589 - DOI - PubMed

LinkOut - more resources